Allos Therapeutics Incorporated

Type: Company
Name: Allos Therapeutics Incorporated
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Anacor Appoints CEO

Paul L. Berns has been appointed president and chief executive officer Anacor Pharmaceuticals, Inc. Mr. Berns previously served as Anacor’s chairman of the board of directors. Mr. Berns succeeds David P. Perry who has served as president and chief executive ... [Published Contract Pharma - Mar 20 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 4 reports

Anacor Pharmaceuticals Appoints New CEO

PALO ALTO, Calif. - Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that the Company’s Board of Directors has appointed Paul L. Berns, Anacor’s Chairman of the Board of Directors, to assume the role of President and Chief Executive Officer, ... [Published PharmaceuticalProcessing - Mar 19 2014]

More Content

All (5) | News (5) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Anacor Appoints CEO [Published Contract Pharma - Mar 20 2014]
Anacor Pharmaceuticals Appoints New CEO [Published PharmaceuticalProcessing - Mar 19 2014]
Anacor Pharma Appoints Paul Berns As President ... [Published RTTNews.com - Mar 19 2014]
Anacor Pharmaceuticals Appoints Paul L. Berns a... [Published Investor's Business Daily - Mar 19 2014]
Anacor Pharmaceuticals Appoints Paul L. Berns a... [Published BioPortfolio - Mar 19 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.